Skip to
  1. Homepage
  2. Research and trials
  3. Research projects
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

15 matching term(s)

Partnership : Academics = Academics, Industrials = Industrials, Financial investitors = Financial investitors

    • AUSTRIA
    • WIEN
    • WIEN
    • DIRECT: disseminate research funded by EC improving treatment options for children suffering from cancer (coordination)
    • St. Anna Kinderkrebsforschung e.V.
    • CCRI - Children's Cancer Research Institute
    • More details
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • National protocol: diagnosis, treatment and survey of endocrine tumors
    • CHU de Reims - Hôpital Robert Debré
    • Service d'Hépato-gastro-entérologie
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • LE KREMLIN-BICÊTRE
    • Genetics of inherited osteochondrodysplasias and disorders of calcium and phosphate metabolism
    • GHU Paris-Sud - Hôpital de Bicêtre
    • Immunologie et génétique du diabète de type 1, Génétique multifactorielle en endocrinologie pédiatrique
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • ORSAY
    • DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
    • Université Paris-Sud XI
    • Institut de Chimie Moléculaire et des Matériaux d'Orsay
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • VILLEJUIF
    • O3K: médicaments anticancéreux oraux hors brevet pour les enfants (coordination)
    • GHU Paris-Sud - CLCC Institut de cancérologie Gustave Roussy
    • Département de cancérologie de l'enfant et de l'adolescent
    • More details
    • FRANCE
    • PAYS DE LA LOIRE
    • ANGERS
    • National protocol: diagnosis, treatment and survey of endocrine tumors
    • CHU d'Angers
    • Département d'endocrinologie, diabétologie et nutrition - Centre de référence des maladies rares de la réceptivité hormonale
    • More details
    • ITALY
    • LOMBARDIA
    • MILANO
    • Surveillance of rare cancers in Italy
    • Fondazione IRCCS Istituto Nazionale dei Tumori
    • S.S. di Epidemiologia Valutativa
    • More details
    • ITALY
    • LOMBARDIA
    • MILANO
    • RARECARE: surveillance of rare cancers in Europe (coordination)
    • Fondazione IRCCS Istituto Nazionale dei Tumori
    • S.S. di Epidemiologia Valutativa
    • More details
    • ITALY
    • PUGLIA
    • SAN GIOVANNI ROTONDO
    • Molecular characterization of patients with primary hyperparathyroidism
    • IRCCS Ospedale Casa Sollievo della Sofferenza - Polamb. Giovanni Paolo II
    • Servizio di Genetica Medica
    • More details
    • ITALY
    • PUGLIA
    • SAN GIOVANNI ROTONDO
    • Molecular characterisation of HRPT2 gene in subjects affected by familial primary hyperparathyroidism from parathyroid carcinoma
    • IRCCS Ospedale Casa Sollievo della Sofferenza - Polamb. Giovanni Paolo II
    • Servizio di Genetica Medica
    • More details
    • PORTUGAL
    • NORTE
    • PORTO
    • Integrated Micro-Nano-OPTO Fluidic systems for high-content diagnosis and studies of rare cancer cells
    • Instituto de Patologia e Imunologia Molecular da Universidade do Porto
    • Genética de Tumores
    • More details
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • NIHR BioResource - Rare Disease: MPMT - Multiple primary malignant tumours
    • Addenbrooke's Hospital
    • Academic Department of Medical Genetics
    • More details
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • NIHR BioResource - Rare Disease: SPEED - Specialist Pathology: Evaluating Exomes in Diagnostics
    • Wellcome Trust/MRC Building
    • Cambridge Institute for Medical Research
    • More details
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • EPOC: European paediatric oncology off-patent medicines consortium (coordination)
    • Newcastle University
    • Northern Institute for Cancer Research
    • More details
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • NIPSIGEN - Clinical translation of non-invasive prenatal diagnosis (NIPD) for single gene disorders (Health Innovation Challenge Fund)
    • Birmingham Women's NHS Foundation Trust
    • Regional Genetics Unit
    • More details